Sugi Predict

Sugi Predict / Compounds / SCHEMBL2174264

SCHEMBL2174264

SCHEMBL2174264

Nc1ncccc1-c1nc2ccc(-c3ccccc3)nc2n1-c1ccc(C2(NC(=O)O)CCC2)cc1

nearest known ligand 0.89

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ AKT1 P31749 20/20 0.89
▸ AKT2 P31751 11/20 0.75
▸ AKT3 Q9Y243 11/20 0.75
▸ CYP2D6 P10635 6/20 0.75
▸ CYP2C9 P11712 6/20 0.75
▸ CYP3A4 P08684 4/20 0.75
▸ CYP2C8 P10632 4/20 0.75
▸ CYP1A2 P05177 2/20 0.75
▸ CYP2C19 P33261 2/20 0.75

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2192652 0.94 AKT1 (1.00) AKT1AKT2AKT3CYP2D6CYP2C9
SCHEMBL2173650 0.92 AKT1 (0.81) AKT1AKT2AKT3CYP2D6CYP2C9
SCHEMBL13570479 0.91 AKT1 (0.74) AKT1AKT2AKT3CYP2D6CYP2C9
SCHEMBL12419899 0.90 AKT1 (0.81) AKT1AKT2AKT3CYP2D6CYP2C9
SCHEMBL30446264 0.90 AKT1 (0.81) AKT1AKT2AKT3CYP2D6CYP2C9
SCHEMBL16104396 0.90 AKT1 (0.78) AKT1AKT2AKT3CYP2D6CYP2C9
SCHEMBL2176121 0.89 AKT1 (0.83) AKT1AKT2AKT3CYP2D6CYP2C9
SCHEMBL2176065 0.88 AKT1 (0.70) AKT1AKT2AKT3CYP2D6CYP2C9
SCHEMBL2188580 0.88 AKT1 (0.77) AKT1AKT2AKT3CYP2D6CYP2C9
SCHEMBL17557959 0.88 AKT1 (0.70) AKT1AKT2AKT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3122748-B1 PROCESS OF PREPARING 3-(3-(4-(1-AMINOCYCLOBUTYL)PHENYL)-5-PHENYL-3H-IMIDAZO[4,5-B]PYRIDIN-2-YL)PYRIDIN-2-AMINE ARQULE INC (US) 2018-09-26 — — EP claimed
US-9834556-B2 Process of preparing 3-(3-(4-aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-B]pyridin-2-YL)pyridin-2-amine ARQULE, INC. (US) 2017-12-05 — — US claimed
EP-3122748-A1 PROCESS OF PREPARING 3-(3-(4-(1-AMINOCYCLOBUTYL)PHENYL)-5-PHENYL-3H-IMIDAZO[4,5-B]PYRIDIN-2-YL)PYRIDIN-2-AMINE ArQule, Inc. (US) 2017-02-01 — — EP claimed
US-20160376270-A1 PROCESS OF PREPARING 3-(3-(4-(1-AMINOCYCLOBUTYL)PHENYL)-5-PHENYL-3H-IMIDAZO[4,5-B]PYRIDIN-2-YL)PYRIDIN-2-AMINE ARQULE, INC. 2016-12-29 — — US claimed
US-9464083-B2 Process of preparing 3-(3-(4-(1-aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-B]pyridin-2-yl)pyridin-2-amine ARQULE INC. (US) 2016-10-11 — — US claimed
WO-2015148464-A1 PROCESS OF PREPARING 3-(3-(4-(1-AMINOCYCLOBUTYL)PHENYL)-5-PHENYL-3H-IMIDAZO[4,5-B]PYRIDIN-2-YL)PYRIDIN-2-AMINE ARQULE INC. (US) 2015-10-01 — — WO claimed
EP-3189036-B1 COMPOSITIONS AND METHODS FOR TREATING PROLIFERATION DISORDERS ARQULE INC (US) 2023-07-19 — — EP disclosed
EP-3122748-B1 PROCESS OF PREPARING 3-(3-(4-(1-AMINOCYCLOBUTYL)PHENYL)-5-PHENYL-3H-IMIDAZO[4,5-B]PYRIDIN-2-YL)PYRIDIN-2-AMINE ARQULE INC (US) 2018-09-26 — — EP disclosed
US-9949981-B2 Compositions and methods for treating proliferation disorders ARQULE, INC. (US) 2018-04-24 — — US disclosed
US-9834556-B2 Process of preparing 3-(3-(4-aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-B]pyridin-2-YL)pyridin-2-amine ARQULE, INC. (US) 2017-12-05 — — US disclosed
EP-3189036-A1 COMPOSITIONS AND METHODS FOR TREATING PROLIFERATION DISORDERS ArQule, Inc. (US) 2017-07-12 — — EP disclosed
EP-3122748-A1 PROCESS OF PREPARING 3-(3-(4-(1-AMINOCYCLOBUTYL)PHENYL)-5-PHENYL-3H-IMIDAZO[4,5-B]PYRIDIN-2-YL)PYRIDIN-2-AMINE ArQule, Inc. (US) 2017-02-01 — — EP disclosed
US-20160376270-A1 PROCESS OF PREPARING 3-(3-(4-(1-AMINOCYCLOBUTYL)PHENYL)-5-PHENYL-3H-IMIDAZO[4,5-B]PYRIDIN-2-YL)PYRIDIN-2-AMINE ARQULE, INC. 2016-12-29 — — US disclosed
US-20160067260-A1 Compositions and Methods for Treating Proliferation Disorders ARQULE, INC. 2016-03-10 — — US disclosed
WO-2016037044-A1 COMPOSITIONS AND METHODS FOR TREATING PROLIFERATION DISORDERS ARQULE, INC. (US) 2016-03-10 — — WO disclosed
WO-2015148464-A1 PROCESS OF PREPARING 3-(3-(4-(1-AMINOCYCLOBUTYL)PHENYL)-5-PHENYL-3H-IMIDAZO[4,5-B]PYRIDIN-2-YL)PYRIDIN-2-AMINE ARQULE INC. (US) 2015-10-01 — — WO disclosed
EP-2519522-B1 SUBSTITUTED IMIDAZOPYRIDINYL-AMINOPYRIDINE COMPOUNDS ARQULE INC (US) 2014-09-24 — — EP disclosed
US-8501770-B2 Substituted imidazopyridinyl-aminopyridine compounds ARQULE, INC. (US) 2013-08-06 — — US disclosed
EP-2519522-A2 SUBSTITUTED IMIDAZOPYRIDINYL-AMINOPYRIDINE COMPOUNDS ArQule, Inc. (US) 2012-11-07 — — EP disclosed
WO-2011082270-A2 SUBSTITUTED IMIDAZOPYRIDINYL-AMINOPYRIDINE COMPOUNDS ARQULE. INC. (US) 2011-07-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160067260-A1 Compositions and Methods for Treating Proliferation Disorders MKI67, HRAS, VHL AKT1 2037/4885AKT2 1350/4885AKT3 1276/4885
US-20160376270-A1 PROCESS OF PREPARING 3-(3-(4-(1-AMINOCYCLOBUTYL)PHENYL)-5-PHENYL-3H-IMIDAZO[4,5-B]PYRIDIN-2-YL)PYRIDIN-2-AMINE PIR, PAH, PNMT AKT1 4063/4885AKT2 4122/4885AKT3 3758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.